Buy Acriol Pro cream 2.5% + 2.5% 100 g
  • Buy Acriol Pro cream 2.5% + 2.5% 100 g

Lidocaine, Prilocaine

Akrikhin
1685 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$138.44
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Local anesthetic agent

Indications

In adults:

- surface anesthesia of the skin during injections (including vaccination), puncture and vascular catheterization and surface surgeries, including minor cosmetic procedures and epilation;

- surface anesthesia of trophic ulcers of the lower extremities during surgical treatment (mechanical cleaning), for example, to remove fibrin, pus and necrotic tissues;

- surface anesthesia of the mucous membrane of the genital organs before carrying out painful manipulations and for pain relief before injections of local anesthetics.

In children:

- surface anesthesia of the skin during injections (including during vaccination), puncture and vascular catheterization and surface surgeries (including during the removal of molluscum contagiosum).

Composition

100 g of cream contains:

active ingredients: lidocaine - 2.5 g, prilocaine - 2.5 g;

excipients: PEG-54 hydrogenated castor oil - 1.9 g; carbomer - 1.0 g; sodium hydroxide - 0.52 g; purified water - up to 100 g

Lidocaine, Prilocaine is marketed under different brands and generic names, and comes in different dosage forms:

Brand nameManufacturerCountryDosage form
Acriol Pro Akrikhin Russia cream
Emla AstraZeneca UK cream

No customer reviews for the moment.

Write your review

Write your review

Lidocaine, Prilocaine

Dosage and Administration

Externally, on the skin or mucous membrane.

Surface anesthesia of trophic ulcers of the lower extremities

During surgical treatment (mechanical cleaning) of trophic ulcers of the lower extremities: a single dose of about 1-2 g / 10 cm2; apply a thick layer of cream on the ulcer surface, not more than 10 g of cream per procedure. Apply an occlusive dressing. Application time: at least 30 minutes.

The opened cream tube is intended for single use, the tube with cream residues should be discarded after use in one patient.

In the case of the treatment of ulcers, in the tissues of which the penetration of the preparation is difficult, the duration of application can be increased to 60 minutes. Mechanical cleaning should be started no later than 10 minutes after removing the cream.

When manipulating the ulcers of the lower extremities, the drug was used up to 15 times over a period of 1-2 months without reducing the effectiveness and increasing the frequency of local reactions.

Genital anesthesia

Skin genitals:

Pain relief before injections of local anesthetics:

Males: 1 g / 10 cm2. Apply the cream with a thick layer on the skin. Application time: 15 min.

Females: 1-2 g / 10 cm2. Apply the cream with a thick layer on the skin. Application time: 60 min.

Surface anesthesia of the mucous membrane of the genital organs:

When removing condylomas and for anesthesia before injections of local anesthetics: approximately 5-10 g of cream, depending on the area of ​​the treated surface. Cream should be applied to the entire surface of the mucous membrane, including the folds of the mucous membrane. Occlusive dressings are required. Application time: 5-10 min. Perform the procedure immediately after removal of the cream.

Children

Anesthesia with the introduction of the needle (including with vaccination), with curettage of molluscum contagiosum and other small surface surgical procedures.

Apply the cream with a thick layer on the skin and cover with an occlusive dressing. The dose should correspond to the treated surface and should not exceed 1 g of cream per 10 cm2.

The strip of the drug Acriol Pro 3.5 cm long approximately corresponds to a dose of 1 g. An increase in the time of application reduces anesthesia.

In children with atopic dermatitis, the application time should be reduced to 30 minutes. Apply the cream with a thick layer on the skin and cover with an occlusive dressing.

Recommendations for applying the drug

Pierce the protective membrane of the aluminum tube using a screw cap, squeeze a sufficient amount of cream from the tube and apply it to the place of the proposed procedure.

With anesthesia of the skin may use occlusive stickers. For anesthesia of trophic ulcers of the lower extremities, use an occlusive PVC dressing. Cover the applied cream with a bandage so that the layer of cream under it is thick and does not squeeze out from under the bandage. Smooth the edges of the dressing gently to avoid cream leaks.

After the recommended time, remove the dressing and cream residue from the surface.

Adverse reactions

The undesirable reactions listed below are distributed according to the frequency of occurrence as follows: very often (≥ 1/10); often (≥ 1/100, <1/10); infrequently (≥ 1/1 000, <1/100); rarely (≥ 1/10 000, <1/1 000), very rarely (

When applied to intact skin

Violations of the skin and subcutaneous tissues: often - transient local reactions in the area of ​​application of the drug, such as pallor, redness and swelling; infrequently - at the first moment after applying a slight burning sensation, itching and feeling of heat (in the area of ​​application of the drug).

General disorders and disorders at the injection site: rarely - allergic reactions, in the most severe cases - anaphylactic shock; methemoglobinemia and / or cyanosis. Reactions in the area of ​​application of the drug, such as hemorrhagic rash or point hemorrhages, especially after prolonged application in children with atopic dermatitis or molluscum contagiosum.Corneal irritation due to accidental contact with eye cream.

When applied to trophic ulcers of the lower extremities

Violations of the skin and subcutaneous tissues: often - transient local reactions in the area of ​​application of the drug, such as pallor, redness and swelling; at the first moment after applying a slight burning sensation, itching and feeling of heat (in the area of ​​application of the drug); infrequently - skin irritation (in the area of ​​application of the drug).

General disorders and disorders at the injection site: rarely - allergic reactions, in the most severe cases - anaphylactic shock.

Contraindications

Hypersensitivity to local anesthetics of the amide type or any other component of the drug.

Premature newborns born with a gestation period of less than 37 weeks.

Newborns weighing less than 3 kg.

Carefully:

Glucose-6-phosphate dehydrogenase deficiency, hereditary or idiopathic methemoglobinemia, widespread neurodermatitis (atopic dermatitis), patients taking class III antiarrhythmic drugs (eg, amiodarone).

Drug interactions

In patients receiving drugs that induce the development of methemoglobinemia (for example, preparations containing a sulfo group), Acryol Pro may increase the concentration of methemoglobin in the blood.

When treating with other local anesthetics and structurally similar drugs (including tocainide), the risk of increased systemic effects when using high doses of the drug should be taken into account.

Special studies to evaluate the interaction of lidocaine / prilocaine with class III antiarrhythmic drugs have not been conducted, caution should be exercised when using the drugs together.

Pharmaceutical interaction: not detected.

Drugs that reduce clearance of lidocaine (for example, cimetidine or beta-blockers), can cause potentially toxic plasma concentrations when using repeated high doses of lidocaine for an extended period of time. This interaction has no clinical significance in the short-term therapy with lidocaine (including the drug Acriol Pro) in the recommended doses.

Pregnancy and Lactation

Pregnancy

Not enough data on the use of the drug in pregnant women. In the course of animal studies, no direct or indirect adverse effects of the drug on pregnancy, fetal development, on the process of childbirth or postnatal development were revealed. Lidocaine and prilocaine penetrate the placental barrier and can be absorbed in the tissues of the fetus. No specific disturbances of the reproductive process, such as an increase in the frequency of malformations or other direct or indirect adverse effects on the fetus, were reported.

Breastfeeding period

Lidocaine and prilocaine are excreted in breast milk in amounts that do not represent a risk to the child, when using the drug in therapeutic doses.

Special instructions

Patients with glucose-6-phosphate dehydrogenase deficiency or hereditary or idiopathic methemoglobinemia are more susceptible to drug-dependent methemoglobinemia.

The efficacy of using the drug in newborns during the procedure of taking blood samples from the heel has not been established.

Care should be taken when applying the drug Acriol Pro around the eyes, because the drug causes eye irritation. Removing protective reflexes can cause irritation or corneal damage. In case of contact with eyes, immediately flush eyes with water or 0.9% sodium chloride solution, and protect eyes until protective reflexes are restored.

Care must be taken when applying the drug to the skin with atopic dermatitis; the application time should be reduced (15-30 minutes).

In children under the age of 3 months, the safety and efficacy of the drug was determined after the application of a single dose. In these children, after application of the drug, a temporary increase in blood levels of methemoglobin up to 13 hours was often observed. However, the observed increase in blood levels of methemoglobin probably has no clinical significance.

Patients taking class III antiarrhythmic drugs (eg, amiodarone) should be monitored and monitored ECG, since may affect the heart activity.

The drug should not be applied to the damaged eardrum or in other cases of possible penetration of the drug into the middle ear.

Do not apply the drug Acriol Pro on open wounds.

Due to the lack of data on the absorption of the drug is not recommended to apply the drug on the mucous membrane of the genital organs in children.

Lidocaine and prilocaine in concentrations above 0.5-2% have bactericidal and antiviral properties. In this regard, it is recommended to take special care when using the drug before the subcutaneous administration of a live vaccine (for example, BCG).

Due to the lack of data, the combined use of the drug Acriol Pro and drugs that cause methemoglobinemia in children aged 0 to 12 months is not recommended.

Overdosage

If the recommended dosage regimen is observed, the development of signs of systemic toxicity is unlikely.

The symptoms of intoxication are probably the same as with other local anesthetics, for example, central nervous system (CNS) arousal, and in severe cases, CNS depression and heart activity.

In rare cases, the development of clinically significant methemoglobinemia was noted. Prilocaine in high doses may cause an increase in methemoglobin. Surface application of 125 mg of prilocaine for 5 hours caused the development of moderate methemoglobinemia in a 3-month-old baby. Superficial application of lidocaine at a dose of 8.6-17.2 mg / kg caused severe intoxication in the newborn.

Treatment: Severe neurological symptoms (convulsions, depression of the central nervous system) require symptomatic treatment, including prescription.

anticonvulsant drugs and, if necessary, mechanical ventilation. In the case of the development of methemoglobinemia, the antidote is methylthioninium chloride (methylene blue).

Because of the slow systemic absorption of the drug, patients should be monitored for several hours after the start of treatment of intoxication.

  • Brand name: Acriol Pro
  • Active ingredient: Lidocaine, Prilocaine
  • Dosage form: Cream for local and external use
  • Manufacturer: Akrikhin
  • Country of Origin: Russia

Studies and clinical trials of Lidocaine, Prilocaine (Click to expand)

  1. Phase diagram and aqueous solubility of the lidocaine-prilocaine binary system
  2. Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase
  3. Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography
  4. Use of lidocaine-prilocaine patch for the mantoux test: Influence on pain and reading
  5. Parallel factor analysis of HPLC-DAD data for binary mixtures of lidocaine and prilocaine with different levels of chromatographic separation
  6. Amethocaine vs lidocaine — prilocaine local anaethetic ointments, for procedural pain in children
  7. Differentiation by in vitro treatment of lidocaine–epinephrine and prilocaine–felypressine in neutrophils
  8. A randomised study of lidocaine and prilocaine for spinal anaesthesia
  9. Plasma levels of lidocaine and prilocaine after application of Oraqix®, a new intrapocket anesthetic, in patients with advanced periodontitis
  10. The anesthetic onset and duration of a new lidocaine/prilocaine gel intra-pocket anesthetic (Oraqix®) for periodontal scaling/root planing
  11. Evaluation of adverse effects of EMLA (lidocaine/prilocaine) cream for the placement of jugular catheters in healthy cats
  12. Optimum usage of prilocaine-lidocaine cream in premature ejaculation
  13. A comparison of prilocaine and lidocaine for intravenous regional anaesthesia for forearm fracture reduction in children
  14. Percutaneous anaesthesia with a lidocaine-prilocaine cream (EMLA®) for cutting split-skin grafts
  15. Is lidocaine-prilocaine cream (EMLA®) always useful for venous puncture in preoperative autologous blood donation ?
  16. Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration
  17. Lidocaïne-prilocaïne-crème bij circumcisie
  18. Safety of lidocaine-prilocaine cream application four times a day in premature neonates: a pilot study
  19. The analgesic efficacy of lidocaine/prilocaine (EMLA) cream during fine-needle aspiration biopsy of thyroid nodules
  20. Comparison of the disposition kinetics of lidocaine and ± prilocaine in 20 patients undergoing intravenous regional anaesthesia during day case surgery
  21. Comparison of topical lidocaine/prilocaine anesthetic cream and local infiltration of 2% lidocaine for episioplasty in mares
  22. Improved application of Lidocaine/Prilocaine cream in children. A randomized and prospectively controlled study of two application regimes
  23. Perianal and intrarectal anaesthesia for transrectal biopsy of the prostate: a prospective randomized study comparing lidocaine-prilocaine cream and placebo
  24. Perianal and intrarectal anaesthesia for transrectal biopsy of the prostate: a prospective randomized study comparing lidocaine-prilocaine cream and placebo

8 other products in the same category:

arrow_upward